BDBM472990 (6aR)-4-((tetrahydro-2H-pyran-2-yl)methyl)- 6,6a,7,8,9,10-hexahydro-5H-pyrazino[1,2- a][1,8]naphthyridine::US10836764, Compound 132

SMILES C(C1CCCCO1)c1ccnc2N3CCNC[C@H]3CCc12

InChI Key InChIKey=MMTJSSRLSCOMQV-UHFFFAOYSA-N

Data  3 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 472990   

Target5-hydroxytryptamine receptor 2C(Human)
Arena Pharmaceuticals

US Patent
LigandPNGBDBM472990((6aR)-4-((tetrahydro-2H-pyran-2-yl)methyl)- 6,6a,7...)
Affinity DataKi:  16.1nMAssay Description:Radioligand binding assays were performed using the commercially available 5-HT2 receptor agonist [125I]DOI as the radioligand and nonspecific bindin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Arena Pharmaceuticals

US Patent
LigandPNGBDBM472990((6aR)-4-((tetrahydro-2H-pyran-2-yl)methyl)- 6,6a,7...)
Affinity DataKi:  212nMAssay Description:Radioligand binding assays were performed using the commercially available 5-HT2 receptor agonist [125I]DOI as the radioligand and nonspecific bindin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2B(Human)
Arena Pharmaceuticals

US Patent
LigandPNGBDBM472990((6aR)-4-((tetrahydro-2H-pyran-2-yl)methyl)- 6,6a,7...)
Affinity DataKi:  1.09E+3nMAssay Description:Radioligand binding assays were performed using the commercially available 5-HT2 receptor agonist [125I]DOI as the radioligand and nonspecific bindin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent